Radiofrequency ablation of renal tumors

Future Oncology

Volumn 4, Issue 1, 2008, Pages 103-111

  Abdellaoui, Adel ^a   Watkinson, Anthony F ^a  

^a ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Radiofrequency ablation; Renal tumor; Thermal ablation

Indexed keywords

ALCOHOL; ARSENIC TRIOXIDE;

CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HEMATOMA; HEMATURIA; HUMAN; KIDNEY CARCINOMA; KIDNEY FUNCTION; KIDNEY TUMOR; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN INJURY; PARESTHESIA; PATIENT SELECTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SKIN INJURY; SURGICAL TECHNIQUE; TREATMENT INDICATION; TUMOR DIAGNOSIS; TUMOR VOLUME; CATHETER ABLATION; COMPUTER ASSISTED THERAPY; INSTRUMENTATION; METHODOLOGY; PATHOLOGY; TREATMENT OUTCOME;

CARCINOMA, RENAL CELL; CATHETER ABLATION; HUMANS; KIDNEY NEOPLASMS; PATIENT SELECTION; THERAPY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 39549086001     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.4.1.103     Document Type: Review

References (63)

1. Motzer RJ, Bander NH, Nanus DM: Renal-cell carcinoma. N. Engl. J. Med. 335(12), 865-875 (1996).
2. Konnak JW, Grossman HB: Renal cell carcinoma as an incidental finding. J. Urol. 134(6), 1094-1096 (1985).
3. Herr HW: Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-yearfollow up. J. Urol. 161(1), 33-34; discussion 34-35 (1999).
4. Rosenthal DI, Alexander A, Rosenberg AE, Springfield D: Ablation of osteoid osteomas with a percutaneously placed electrode: a new procedure. Radfolaff 183(1), 29-33 (1992).
5. Rossi S, di Stasi M, Buscarini E et al.: Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am. J. Roentgenol. 167(3), 759-768 (1996).
6. Livraghi T, Goldberg SN, Monti F et al.: Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology 2O2(1), 205-210 (1997).
7. Jiao, LR, Hansen PD, Havlik R, Mitry RR, Pignatelli M, Habib N: Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Am. J. Surg. 177(4), 303-306 (1999).
8. Goldberg SN, Gazelle GS, Mueller PR: Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am. J. Roentgenol. 174(2), 323-331 (2000).
9. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 217 (3), 633-646 (2000).
10. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK: Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88(11), 2452-2463 (2000).
11. Rehman J, Landman J, Lee D et al.: Needle-based ablation of renal parenchyma using microwave, cryoablation, impedance- and temperature-based monopolar and bipolar radiofrequency, and liquid and gel chemoablation: laboratory studies and review of the literature. J. Endourol. 18(1), 83-104 (2004).
12. Rossi, S, Fornari F, Pathies C, Buscarini L: Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori 76(1), 54-57 (1990).
13. Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI: Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad. Radiol. 2(5), 399-404 (1995).
14. de Baere T, Denys A, Wood BJ et al.: Radiofrequency liver ablation: experimental comparative study of water-cooled versus expandable systems. AJR Am. J. Roentgenol. 176(1), 187-192 (2001).
15. Lorentzen T: A cooled needle electrode for radiofrequency tissue ablation: thermodynamic aspects of improved performance compared with conventional needle design. Acad Radiol. 3(7), 556-563 (1996).
16. Goldberg SN, Hahn PF, Tanabe KK et al.: Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J. Vasc. Interv. Radiol. 9(1 Pt 1), 101-111 (1998).
17. Jacobsohn KM, Ahrar K, Wood CG, Matin SF: Is radiofrequency ablation safe for solitary kidneys? Urology 69(5), 819-823; discussion 823 (2007).
18. McGovern FJ, Wood BJ, Goldberg SN, Mueller PR: Radio frequency ablation of renal cell carcinoma via image guided needle electrodes. J. Urol. 161(2), 599-600 (1999).
19. Wood BJ, Grippo J, Pavlovich CP; Percutaneous radio frequency ablation for hematuria. J. Urol. 166(6), 2303-2304 (2001).
20. McLaughlin CA, Chen MY, Torti FM, Hall MC, Zagoria RJ: Radiofrequency ablation of isolated local recurrence of renal cell carcinoma after radical nephrectomy. AJR Am. J. Roentgenol. 181 (1), 93-94 (2003).
21. Aron M, Hegarty NJ, Remer E, O'Malley C. Goldfarb D, Kaouk JH: Percutaneous radiofrequency ablation of tumor in transplanted kidney. Urology 69(4), E775-E777 (2007).
22. Goeman L, Joniau S, Oyen R, van Poppel H: Percutaneous ultrasound-guided radiofrequency ablation of recurrent renal cell carcinoma in renal allograft after partial nephrectomy. Urology 67(1), 199 (2006).
23. Zagoria RJ, Chen MY, Kavanagh PV, Torti FM: Radio frequency ablation of lung metastases from renal cell carcinoma. J. Urol. 166(5), 1827-1828 (2001).
24. Gervais DA, Arenano RS, Mueller PR: Percutaneous radiofrequency ablation of nodal metastases. Cardiovasc. Intervent. Radiol. 25(6), 547-549 (2002).
25. Mukai T Sato S, Iguchi T et al: Effects of radiofrequency ablation on individual renal function: assessment by technetium-99m mercaptoacetyltriglycine renal scintigraphy. Acta Med. Okayama 60(2), 85-91 (2006).
26. Nahum Goldberg S, Dupuy DE: Image-guided radiofrequency tumor ablation: challenges and opportunities - Part 1. J. Vasc. Interv Radiol. 12(9), 1021-1032 (2001).
27. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR: Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radioloqy 226(2), 417-424 (2003).
28. Pavlovich CP, Walther MM, Choyke PL et al.: Percutaneous radio frequency ablation of small renal tumors: initial results. J. Urol. 167(1),10-15 (2002).
29. Farrell MA, Charboneau WJ, DiMarco DS et al.: Imaging-guided radiofrequency ablation of solid renal tumors. AJR Am. J. Roentgenol. 180(6), 1509-1513 (2003).
30. Johnson DB, Saboorlan MH, Duchene DA, Ogan K, Cadeddu JA: Nephrectomy after radiofrequency ablation-induced ureteropelvic junction obstruction: potential complication and long-term assessment of ablation adequacy. Urlogy 62(2), 351-352 (2003).
31. Dodd GD 3rd, Soulen MC, Kane RA et al.: Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 20(1), 9-27 (2000).
32. Roy-Choudhury SH, Cast JE, Cooksey G, Puri S, Breen DJ: Early experience with percutaneous radiofrequency ablation of small solid renal masses. AJR Am. J. Roentgenol. 180(4), 1055-1061 (2003).
33. Hwang JJ, Walther MM, Pautler SE et al.: Radio frequency ablation of small renal tumors: intermediate results. J Urol. 171(5). 1814-1818 (2004).
34. Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ: Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am. J. Roentgenol. 180(6), 1503-1508 (2003).
35. Zlotta AR, Wildschutz T, Raviv G et al.: Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J. Endourol. 11 (4), 251-258 (1997).
36. Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE: Oncologic, efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am. J. Roentgenol. 189(2), 429-436 (2007).
37. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR: Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am. J. Roentgenol. 185(1), 64-71 (2005).
38. Weizer AZ, Raj GV, O'Connell M, Robertson CN, Nelson RC, Polascik TJ: Complications after percutaneous radiofrequency ablation of renal tumors. Urology 66(6), 1176-1180 (2005).
39. Matsumoto ED, Johnson DB, Ogan K et al.: Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors. Urology 65 (5), 877-881 (2005).
40. Breen DJ, Rutherford EE, Stedman B et al.: Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc. Intervent. Radiol. 30(5), 936-942 (2007).
41. Fotiadis NI, Sabharwal T, Morales JP, Hodgson DJ, O'Brien TS, Adam A: Combined percutaneous radiofrequency ablation and ethanol injection of renal tumors: midterm results. Eur. Urol. 52(3), 777-784 (2007).
42. Johnson DB, Solomon SB, Su LM et al.: Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J. Urol. 172(3), 874-877 (2004).
43. Rhim H, Dodd GD 3rd, Chintapalli KN et al.: Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 24 (1), 41-52 (2004).
44. Rhim H, Kim YS, Heo JN et al.: Radiofrequency thermal ablation of hepatic cyst. J. Vasc. Interv. Radiol. 15 (1 Pt 1), 95-96 (2004).
45. Roach H, Whittlestone T, Callaway MP: Life-threatening hematuria requiring transcatheter embolization following radiofrequency ablation of renal cell carcinoma. Cardiovasc. Intervent. Radiol, 29(4), 672-674 (2006).
46. Rendon RA, Gertner MR, Sherar MD et al.: Development of a radiofrequency based thermal therapy technique in an in vivo porcine model for the treatment of small renal masses. J. Urol. 166(1), 292-298 (2001).
47. Boss A, Clasen S, Kuczyk M et al.: Thermal damage of the genitofemoral nerve due to radiofrequency ablation of renal cell carcinoma: a potentially avoidable complication. AJR Am. J. Roentgenol. 185(6), 1627-1631 (2005).
48. Lee SJ, Choyke IT, Locklin JK, Wood BJ: Use of hydrodissection to prevent nerve and muscular damage during radiofrequency ablation of kidney tumors. J. Vasc. Interv. Radiol. 17(12), 1967-1969 (2006).
49. Yamasaki T, Kurokawa E. Shirabashi H. Kusano N, Hironaka K, Okita K: Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy. Cancer 95(11), 2353-2360 (2002).
50. Griffin RJ, Lee SH, Rood KL et al.: Use of arsenic trioxide, as an antivascular and thermosensitizing agent in solid tumors. Neoplasia 2(6), 555-560 (2000).
51. Griffin RJ, Monzen H, Williams BW, Park H, Lee SH, Song CW. Arsenic trioxide induces selective tumor vascular damage via oxidative stress and increases thermosensitivity of tumors. Int. 33J. Hyperthemia 19(6), 575-589 (2003).
52. Lew YS, Brown SL, Griffin RJ, Song CW, Kim JH: Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown. Cancer Res. 59(24), 6033-6037 (1999).
53. Hines-Peraita, A, Sukhatme V, Regan M, Signoretti S, Liu ZJ, Goldberg SN: Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models. Radiology 240(1), 82-89 (2006).
54. Munver R, Threatt CB, Delvecchio FC, Premiger GM, Polascik TJ: Hypertonic saline-augmented radiofrequency ablation of the VX-2 tumor implanted in the rabbit kidney: a short-term survival pilot study. Urology 60(1), 170-175 (2002).
55. Svatek RS, Sims R, Anderson JK, Abdel-Aziz K, Cadeddu JA: Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation. Urology 67(3), 508-512 (2006).
56. Park S, Anderson JK, Matsumoto ED, Lotan Y, Josephs S, Cadeddu JA: Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol. 20(8), 569-573 (2006).
57. Sabharwal R, Vladica P: Renal tumors: technical success and early clinical experience with radiofrequency ablation of 18 tumors. Cardiovasc. Intervent. Radiol. 29(2), 202-209 (2006).
58. Memarsadeghi M, Schmook T, Remzi M et al.: Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients. Eur. J. Radiol. 59(2), 183-189 (2006).
59. Varkarakis IM, Allaf ME, Inagaki T et al.: Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup. J. Urol. 174(2), 456-460; discussion 460 (2005).
60. Lewin JS, Nour SG, Connell CF et al.: Phase II clinical trial of interactive MR imaging-guided interstitial radiofrequency thermal ablation of primary kidney tumors: initial experience. Radiology 232 (3), 835-845 (2004).
61. Ukimura O, Kawauchi A, Fujito A et al.: Radio-frequency ablation of renal cell carcinoma in patients who were at significant risk. Int J. Urol. 11 (12), 1051-1057 (2004).
62. Su LM, Jarrett TW Chan DY, Kavoussi LR, Solomon SB: Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results. Urology 61(4 Suppl. 1), 26-33 (2003).
63. Ogan K, Jacomides L, Dolmatch BL et al.: Percutaneous radiofrequency ablation of renal tumors: technique, limitations, and morbidity: Urology 60(6), 954-958 (2002).